3United States Renal Data System. 201)7 USRDS Annual Data Report[EB/OL]. http://www. usrds. org/2007/ref/L_vase_ access_07. pdf.
4Hoen B,Paul-Dauphin A, Hestin D, et al. EPIBACDIAL: a multicenter prospective study of risk factors for baeteremia in chronic hemodialysis patients[J]. J Am Soc Nephrol, 1998, 9:869 - 876.
5Mermel A, Farr B, Sherertz R, et al. Guidelines for the management of intravascular catheter-related infections[J]. Infect Control Hosp Epidemiol,2001,22( 4 ) :222 - 242.
6Schinabeck M, Ghannoum M. Catheter-related infectionsdiagnosis, treatment, and prevention[J ]. Clin Microbiol Newsl,2003,25(15) :113- 118.
7Cheesbrough J, Finch R, Burden R. A prospective study of the mechanisms of infection associated with hemodialysis catheters[J]. J Infect Dis, 1986,154 : 579 - 589.
8Almirall J,Gonzalez J, Rello J,et al. Infection of hemodialysis catheters: incidence and mechanisms [J]. Am J Nephrol, 1989,9:454- 459.
9Kairairtis LK, Gottlieh T. Outcome and complications of temporary haemodialysis catheters [ J ]. Nephrol Dial Transplant, 1999,14 : 1 720 - 1 714.
10Sesso R, Barbosa D, Leme IL, et al. Staphylococcus aureus prohpylaxia in hemodialysis patients using central venous catheter: effect of mupirocin ointmen[J]. J Am Soc Nephrol, 1998,9:1 085-1 092.
